NCT07148908 Animal and Microbial-based Dietary Protein Efficiency in Adults
| NCT ID | NCT07148908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Daniel Moore |
| Condition | Protein Metabolism |
| Study Type | INTERVENTIONAL |
| Enrollment | 13 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 13 participants in total. It began in 2025-07-01 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Given the relatively high carbon footprint and sustainability of animal-based proteins, there is a growing interest in determining the nutritional quality non-animal-based protein sources. The overall objective of this investigation is to examine the impact of different animal and microbial-based protein sources to support whole body protein synthesis in adults. To do this, investigators will employ a 'breath test' method developed in our laboratory as well as urine sampling. The results of this study will allow us to better understand the impact of dietary protein quality for maintaining health and body protein mass in adults.
Eligibility Criteria
Inclusion Criteria: * Healthy, male and female, recreationally-active participants. * Healthy will be defined as screened by the PAR-Q+ (Appendix B) and The Physical Activity Readiness Questionnaire (Appendix C). * Participants will be aged 18-45 years old. * Participants are willing to abide by the compliance rules of this study. * Self-reported regular menstrual cycle (25-35d) within the last 3 months (female participants). * Use of monophasic combined oral contraceptives (COC) containing 21 active pills (e.g., Yaz, Marvelon, Cyclen, etc.; the brand of COC will be recorded) (female participants). Exclusion Criteria: * Inability to adhere to any of the compliance rules judged by principal investigator (e.g. dairy protein or yeast allergy). * Self-reported regular tobacco use. * Self-reported illicit drug use (e.g., growth hormone, testosterone, etc.). * Individuals who have participated in studies within the past year involving any of the stable isotopes in the study. * Use of multiphasic COCs due to the difficulty of controlling for hormonal fluctuations in such formulations (female participants). * Use of COCs containing \>21 active pills per cycle due to potential differences in their effect on metabolism (female participants). * Use of other forms of hormonal contraception (e.g., progestin-only pill, hormonal IUD, intravaginal ring) (female participants). * Not currently or previously (in the past 6 months) on a vegan diet
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07148908 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Protein Metabolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07148908 currently recruiting?
Yes, NCT07148908 is actively recruiting participants. Contact the research team at drmoore@utoronto.ca for enrollment information.
Where is the NCT07148908 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT07148908 clinical trial?
NCT07148908 is sponsored by Daniel Moore. The trial plans to enroll 13 participants.